Zhuqing Liu

Zhuqing Liu is a Director at Cerevel Therapeutics since April 2022, with extensive experience in chemical process development and manufacturing. Previously, Zhuqing held the position of Associate Director at Johnson Matthey from November 2020 to September 2022. Zhuqing's career at Merck Sharp & Dohme spanned over 11 years, where roles included Senior Scientist in various departments, with notable achievements in chemical risk assessment, analytical method development, and supporting late-stage projects. Zhuqing's academic background includes a PhD in Organic Chemistry from the University of Utah and a Master's in Chemistry from Mississippi State University, complemented by postdoctoral research at the University of Pennsylvania.